| Health / Medical Topics |
IMC-A12
A substance being studied in the treatment of some types of cancer. It is a monoclonal antibody that is made in the laboratory and can bind to substances in the body. IMC-A12 blocks the action of a protein needed for cell growth and may kill cancer cells. It is a type of insulin-like growth factor-1 receptor (IGF-1R) inhibitor. Also called cixutumumab. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance being studied in the treatment of glioblastoma (a type of brain tumor) that has come back. It binds to receptors…
A monoclonal antibody that selectively binds with KDR and blocks the vascular endothelial growth factor-induced endothelial cell proliferation and prevents angiogenesis. …
A substance being studied in the treatment of breast cancer that has come back. It binds to receptors for a protein called…
A drug used to treat mantle cell lymphoma in patients who have already received other treatment. It is also being studied in…
A drug used to treat different types of leukemia and other cancers of the blood, gastrointestinal stromal tumors, skin tumors called dermatofibrosarcoma…
An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain…
